Clinical trial
Predictors of the Response to Adalimumab in Rheumatoid Arthritis
NCT00234234 is registered in ClinicalTrials.gov with University Hospital, Rouen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Predictors of the Response to Adalimumab in Rheumatoid Arthritis
- Lead sponsor
- University Hospital, Rouen
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2006
- Completion date
- December 31, 2008
- Enrollment
- 200 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
rheumatoid arthritis